Kaplan–Meier survival analysis revealed a longer progression-free survival (PFS) and overall survival (OS) in ovarian cancer patients with low PAPSS1 expression and high ESR1 expression than those with low ESR1 and high PAPSS1(Fig. 6A). The gene discussed is PAPSS1; the disease is ovarian carcinoma.